Listed

Ironwood Pharmaceuticals Inc

IRWDNasdaqCIK 1446847HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$113.0m, Q2 FY2026
Operating income$79.3m, Q2 FY2026
Net income$51.3m, Q2 FY2026
Ironwood Pharmaceuticals Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m114Revenue, Q3 FY2023, three months to 2023-09-30$113.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure118Revenue, Q4 FY2023, three months to 2023-12-31$117.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure74.9Revenue, Q1 FY2024, three months to 2024-03-31$74.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure94.4Revenue, Q2 FY2024, three months to 2024-06-30$94.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure91.6Revenue, Q3 FY2024, three months to 2024-09-30$91.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure90.5Revenue, Q4 FY2024, three months to 2024-12-31$90.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure41.1Revenue, Q1 FY2025, three months to 2025-03-31$41.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure85.2Revenue, Q2 FY2025, three months to 2025-06-30$85.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure122Revenue, Q3 FY2025, three months to 2025-09-30$122.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure47.7Revenue, Q4 FY2025, three months to 2025-12-31$47.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure107Revenue, Q1 FY2026, three months to 2026-03-31$106.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure113Revenue, Q2 FY2026, three months to 2026-06-30$113.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m33.0Research and development, Q3 FY2023, three months to 2023-09-30$33.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure35.7Research and development, Q4 FY2023, three months to 2023-12-31$35.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001558370-25-004072. Derived: 12-month figure less the 9-month figure.Report this figure25.8Research and development, Q1 FY2024, three months to 2024-03-31$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure30.4Research and development, Q2 FY2024, three months to 2024-06-30$30.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure29.8Research and development, Q3 FY2024, three months to 2024-09-30$29.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure25.4Research and development, Q4 FY2024, three months to 2024-12-31$25.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure27.4Research and development, Q1 FY2025, three months to 2025-03-31$27.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure23.4Research and development, Q2 FY2025, three months to 2025-06-30$23.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure22.5Research and development, Q3 FY2025, three months to 2025-09-30$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure21.9Research and development, Q4 FY2025, three months to 2025-12-31$21.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure21.9Research and development, Q1 FY2026, three months to 2026-03-31$21.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure22.4Research and development, Q2 FY2026, three months to 2026-06-30$22.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Selling, general and administrative$m36.0Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$36.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure38.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$38.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-31, accession 0001558370-25-004072. Derived: 12-month figure less the 9-month figure.Report this figure37.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$37.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure37.0Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$37.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure36.1Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$36.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure33.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$33.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure24.3Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$24.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure16.8Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$16.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure21.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$21.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure19.3Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$19.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure12.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$12.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure11.3Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$11.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Operating income$m40.0Operating income, Q3 FY2023, three months to 2023-09-30$40.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure37.6Operating income, Q4 FY2023, three months to 2023-12-31$37.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004072. Derived: 12-month figure less the 9-month figure.Report this figure11.0Operating income, Q1 FY2024, three months to 2024-03-31$11.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure25.0Operating income, Q2 FY2024, three months to 2024-06-30$25.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure25.6Operating income, Q3 FY2024, three months to 2024-09-30$25.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure31.5Operating income, Q4 FY2024, three months to 2024-12-31$31.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure(29.1)Operating income, Q1 FY2025, three months to 2025-03-31−$29.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure45.3Operating income, Q2 FY2025, three months to 2025-06-30$45.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure75.5Operating income, Q3 FY2025, three months to 2025-09-30$75.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure6.8Operating income, Q4 FY2025, three months to 2025-12-31$6.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure72.6Operating income, Q1 FY2026, three months to 2026-03-31$72.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure79.3Operating income, Q2 FY2026, three months to 2026-06-30$79.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Interest expense$m9.8Interest expense, Q3 FY2023, three months to 2023-09-30$9.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure8.4Interest expense, Q4 FY2023, three months to 2023-12-31$8.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-16, accession 0001558370-24-001275. Derived: 12-month figure less the 9-month figure.Report this figure7.2Interest expense, Q1 FY2024, three months to 2024-03-31$7.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure7.5Interest expense, Q2 FY2024, three months to 2024-06-30$7.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure9.4Interest expense, Q3 FY2024, three months to 2024-09-30$9.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure8.9Interest expense, Q4 FY2024, three months to 2024-12-31$8.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure8.1Interest expense, Q1 FY2025, three months to 2025-03-31$8.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure8.4Interest expense, Q2 FY2025, three months to 2025-06-30$8.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure8.4Interest expense, Q3 FY2025, three months to 2025-09-30$8.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure7.9Interest expense, Q4 FY2025, three months to 2025-12-31$7.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure9.1Interest expense, Q1 FY2026, three months to 2026-03-31$9.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure7.2Interest expense, Q2 FY2026, three months to 2026-06-30$7.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Income tax$m18.0Income tax, Q3 FY2023, three months to 2023-09-30$18.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure32.1Income tax, Q4 FY2023, three months to 2023-12-31$32.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0001558370-25-004072. Derived: 12-month figure less the 9-month figure.Report this figure9.1Income tax, Q1 FY2024, three months to 2024-03-31$9.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure19.7Income tax, Q2 FY2024, three months to 2024-06-30$19.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure13.7Income tax, Q3 FY2024, three months to 2024-09-30$13.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure21.7Income tax, Q4 FY2024, three months to 2024-12-31$21.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure1.1Income tax, Q1 FY2025, three months to 2025-03-31$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure14.2Income tax, Q2 FY2025, three months to 2025-06-30$14.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure27.9Income tax, Q3 FY2025, three months to 2025-09-30$27.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure2.7Income tax, Q4 FY2025, three months to 2025-12-31$2.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure24.4Income tax, Q1 FY2026, three months to 2026-03-31$24.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure22.4Income tax, Q2 FY2026, three months to 2026-06-30$22.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Net income$m15.3Net income, Q3 FY2023, three months to 2023-09-30$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(1.1)Net income, Q4 FY2023, three months to 2023-12-31−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(4.2)Net income, Q1 FY2024, three months to 2024-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.9)Net income, Q2 FY2024, three months to 2024-06-30−$860.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure3.6Net income, Q3 FY2024, three months to 2024-09-30$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure2.3Net income, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(37.4)Net income, Q1 FY2025, three months to 2025-03-31−$37.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure23.6Net income, Q2 FY2025, three months to 2025-06-30$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure40.1Net income, Q3 FY2025, three months to 2025-09-30$40.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(2.3)Net income, Q4 FY2025, three months to 2025-12-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure40.8Net income, Q1 FY2026, three months to 2026-03-31$40.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure51.3Net income, Q2 FY2026, three months to 2026-06-30$51.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Diluted EPS$ per share0.09Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(0.01)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(0.03)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.01)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure0.02Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure0.01Diluted EPS, Q4 FY2024, three months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.23)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure0.14Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure0.23Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.01)Diluted EPS, Q4 FY2025, three months to 2025-12-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure0.24Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure0.31Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Basic EPS$ per share0.10Basic EPS, Q3 FY2023, three months to 2023-09-30$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(0.01)Basic EPS, Q4 FY2023, three months to 2023-12-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(0.03)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.01)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure0.02Basic EPS, Q3 FY2024, three months to 2024-09-30$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure0.01Basic EPS, Q4 FY2024, three months to 2024-12-31$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.23)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure0.15Basic EPS, Q2 FY2025, three months to 2025-06-30$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure0.25Basic EPS, Q3 FY2025, three months to 2025-09-30$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(0.01)Basic EPS, Q4 FY2025, three months to 2025-12-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure0.25Basic EPS, Q1 FY2026, three months to 2026-03-31$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure0.31Basic EPS, Q2 FY2026, three months to 2026-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure

Balance sheet

Cash and equivalents$79.1m, Q2 FY2026
Long-term debt$199.5m, Q3 FY2025
Shareholders' equity−$161.8m, Q2 FY2026
Ironwood Pharmaceuticals Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m110Cash and equivalents, Q3 FY2023, at 2023-09-30$110.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure92.2Cash and equivalents, FY2023, at 2023-12-31$92.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure122Cash and equivalents, Q1 FY2024, at 2024-03-31$121.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure106Cash and equivalents, Q2 FY2024, at 2024-06-30$105.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure88.2Cash and equivalents, Q3 FY2024, at 2024-09-30$88.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure88.6Cash and equivalents, FY2024, at 2024-12-31$88.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure108Cash and equivalents, Q1 FY2025, at 2025-03-31$108.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure92.9Cash and equivalents, Q2 FY2025, at 2025-06-30$92.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure140Cash and equivalents, Q3 FY2025, at 2025-09-30$140.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure215Cash and equivalents, FY2025, at 2025-12-31$215.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure220Cash and equivalents, Q1 FY2026, at 2026-03-31$220.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure79.1Cash and equivalents, Q2 FY2026, at 2026-06-30$79.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Current assets$m254Current assets, Q3 FY2023, at 2023-09-30$253.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure233Current assets, FY2023, at 2023-12-31$233.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure208Current assets, Q1 FY2024, at 2024-03-31$208.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure178Current assets, Q2 FY2024, at 2024-06-30$178.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure179Current assets, Q3 FY2024, at 2024-09-30$178.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure182Current assets, FY2024, at 2024-12-31$182.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure161Current assets, Q1 FY2025, at 2025-03-31$160.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure192Current assets, Q2 FY2025, at 2025-06-30$191.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure274Current assets, Q3 FY2025, at 2025-09-30$273.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure274Current assets, FY2025, at 2025-12-31$274.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure332Current assets, Q1 FY2026, at 2026-03-31$332.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure199Current assets, Q2 FY2026, at 2026-06-30$199.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Total assets$m524Total assets, Q3 FY2023, at 2023-09-30$524.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure471Total assets, FY2023, at 2023-12-31$471.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure439Total assets, Q1 FY2024, at 2024-03-31$438.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure396Total assets, Q2 FY2024, at 2024-06-30$395.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure390Total assets, Q3 FY2024, at 2024-09-30$389.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure351Total assets, FY2024, at 2024-12-31$350.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure327Total assets, Q1 FY2025, at 2025-03-31$327.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure343Total assets, Q2 FY2025, at 2025-06-30$342.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure396Total assets, Q3 FY2025, at 2025-09-30$396.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure397Total assets, FY2025, at 2025-12-31$396.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure435Total assets, Q1 FY2026, at 2026-03-31$434.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure285Total assets, Q2 FY2026, at 2026-06-30$285.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Current liabilities$m281Current liabilities, Q3 FY2023, at 2023-09-30$280.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure276Current liabilities, FY2023, at 2023-12-31$276.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure252Current liabilities, Q1 FY2024, at 2024-03-31$252.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure45.5Current liabilities, Q2 FY2024, at 2024-06-30$45.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure49.4Current liabilities, Q3 FY2024, at 2024-09-30$49.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure38.8Current liabilities, FY2024, at 2024-12-31$38.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure48.1Current liabilities, Q1 FY2025, at 2025-03-31$48.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure233Current liabilities, Q2 FY2025, at 2025-06-30$232.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure243Current liabilities, Q3 FY2025, at 2025-09-30$242.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure242Current liabilities, FY2025, at 2025-12-31$242.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure236Current liabilities, Q1 FY2026, at 2026-03-31$236.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure32.9Current liabilities, Q2 FY2026, at 2026-06-30$32.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Total liabilities$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported659Total liabilities, FY2025, at 2025-12-31$658.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figurenot reported447Total liabilities, Q2 FY2026, at 2026-06-30$447.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure
Long-term debt$m397Long-term debt, Q3 FY2023, at 2023-09-30$397.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure398Long-term debt, FY2023, at 2023-12-31$397.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure398Long-term debt, Q1 FY2024, at 2024-03-31$398.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure199Long-term debt, Q2 FY2024, at 2024-06-30$198.6m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure199Long-term debt, Q3 FY2024, at 2024-09-30$198.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure199Long-term debt, FY2024, at 2024-12-31$199.0m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure199Long-term debt, Q1 FY2025, at 2025-03-31$199.2m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure199Long-term debt, Q2 FY2025, at 2025-06-30$199.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure200Long-term debt, Q3 FY2025, at 2025-09-30$199.5m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figurenot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m(323)Shareholders' equity, Q3 FY2023, at 2023-09-30−$323.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure(346)Shareholders' equity, FY2023, at 2023-12-31−$346.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-31, accession 0001558370-25-004072.Report this figure(331)Shareholders' equity, Q1 FY2024, at 2024-03-31−$330.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure(322)Shareholders' equity, Q2 FY2024, at 2024-06-30−$321.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure(311)Shareholders' equity, Q3 FY2024, at 2024-09-30−$311.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure(301)Shareholders' equity, FY2024, at 2024-12-31−$301.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001104659-26-020489.Report this figure(334)Shareholders' equity, Q1 FY2025, at 2025-03-31−$334.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure(308)Shareholders' equity, Q2 FY2025, at 2025-06-30−$308.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure(264)Shareholders' equity, Q3 FY2025, at 2025-09-30−$264.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure(262)Shareholders' equity, FY2025, at 2025-12-31−$261.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure(217)Shareholders' equity, Q1 FY2026, at 2026-03-31−$217.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure(162)Shareholders' equity, Q2 FY2026, at 2026-06-30−$161.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure

Cash flow

Operating cash flow$58.3m, Q2 FY2026
Capital expenditure−$1.0k, Q4 FY2025
Ironwood Pharmaceuticals Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m32.5Operating cash flow, Q3 FY2023, three months to 2023-09-30$32.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001558370-24-014909. Derived: 9-month figure less the 6-month figure.Report this figure35.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$35.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001558370-25-004072. Derived: 12-month figure less the 9-month figure.Report this figure45.0Operating cash flow, Q1 FY2024, three months to 2024-03-31$45.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure33.5Operating cash flow, Q2 FY2024, three months to 2024-06-30$33.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001558370-25-011050. Derived: 6-month figure less the 3-month figure.Report this figure9.9Operating cash flow, Q3 FY2024, three months to 2024-09-30$9.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-108795. Derived: 9-month figure less the 6-month figure.Report this figure15.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$15.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure20.0Operating cash flow, Q1 FY2025, three months to 2025-03-31$20.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure(15.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001104659-26-091987. Derived: 6-month figure less the 3-month figure.Report this figure47.6Operating cash flow, Q3 FY2025, three months to 2025-09-30$47.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-10, accession 0001104659-25-108795. Derived: 9-month figure less the 6-month figure.Report this figure74.6Operating cash flow, Q4 FY2025, three months to 2025-12-31$74.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure5.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure58.3Operating cash flow, Q2 FY2026, three months to 2026-06-30$58.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001104659-26-091987. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$49.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001558370-24-014909. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2023, three months to 2023-12-31$211.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001558370-25-004072. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$68.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$58.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-11, accession 0001558370-25-011050. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001104659-25-108795. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001104659-26-091987. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$2.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-10, accession 0001104659-25-108795. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001104659-26-020489. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)167.18m, Q2 FY2026
Ironwood Pharmaceuticals Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares184Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30184,465,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001558370-23-018589.Report this figure187Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31186,680,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001558370-24-007640.Report this figure155Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30155,367,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001558370-24-011590.Report this figure187Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30186,891,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001558370-24-014909.Report this figure158Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31157,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001558370-25-007406.Report this figure159Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30159,014,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001558370-25-011050.Report this figure160Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30160,232,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure161Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31160,974,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure177Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30176,837,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure178Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30177,764,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-10, accession 0001104659-25-108795.Report this figure167Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31166,690,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001104659-26-057110.Report this figure167Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30167,179,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure

Shares outstanding: 165.24mShares outstanding, period not labelled, at 2026-07-31165,239,947 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001104659-26-091987.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.